These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24777492)

  • 1. Detoxification treatments for opiate dependent adolescents.
    Minozzi S; Amato L; Bellisario C; Davoli M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006749. PubMed ID: 24777492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance treatments for opiate -dependent adolescents.
    Minozzi S; Amato L; Bellisario C; Davoli M
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007210. PubMed ID: 24957634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detoxification treatments for opiate dependent adolescents.
    Minozzi S; Amato L; Davoli M
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006749. PubMed ID: 19370651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine for managing opioid withdrawal.
    Gowing L; Ali R; White JM; Mbewe D
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Jahanfar S; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006318. PubMed ID: 33165953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance treatments for opiate dependent adolescent.
    Minozzi S; Amato L; Davoli M
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007210. PubMed ID: 19370679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological therapies for management of opium withdrawal.
    Rahimi-Movaghar A; Gholami J; Amato L; Hoseinie L; Yousefi-Nooraie R; Amin-Esmaeili M
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007522. PubMed ID: 29929212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.
    Carney T; Van Hout MC; Norman I; Dada S; Siegfried N; Parry CD
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012254. PubMed ID: 32068247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002021. PubMed ID: 28553701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.
    Amato L; Minozzi S; Davoli M; Vecchi S
    Cochrane Database Syst Rev; 2011 Sep; (9):CD005031. PubMed ID: 21901695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphaâ‚‚-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.
    Amato L; Minozzi S; Davoli M; Vecchi S; Ferri MM; Mayet S
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005031. PubMed ID: 18843675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.
    Amato L; Minozzi S; Davoli M; Vecchi S; Ferri MM; Mayet S
    Cochrane Database Syst Rev; 2008 Jul; (3):CD005031. PubMed ID: 18646118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002025. PubMed ID: 16625553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD002025. PubMed ID: 19588330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002025. PubMed ID: 15495026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.